Back to Search
BENJAMIN BETANCOURT, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1710977624Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
3679(PR)
Research & Publications (8)
Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
PMID 19291119·Int Wound J·2009
3-trial
Management of a hypertensive ulcer with an epidermal growth factor-based formulation.
PMID 18833895·J Wound Care·2008
5-case
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
PMID 17953679·Int Wound J·2007
4-observational
Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients.
PMID 16622616·J Thromb Thrombolysis·2006
6-review
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
PMID 16262910·BMC Clin Pharmacol·2005
8-other
Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.
PMID 15576019·J Pharm Pharm Sci·2004
3-trial
Streptokinase for the treatment of acute ischaemic stroke : towards better strategies.
PMID 12665394·CNS Drugs·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- FERNADEZ JUNCOS AVE. 1501, SUITE 401 BETANCOURT BUILDING
SANTURCE, PR 00910 - Phone
- (787) 728-7240
Quick Facts
- NPI
- 1710977624
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile